Evaluation of applicability of the online version of HADS-D for depression phenotype screening in the general population
AA Kibitov, AS Rakitko, ED Kasyanov, GV Rukavishnikov, KA Kozlova, VV Ilinsky, NG Neznanov, GE Mazo, AO Kibitov
doi: https://doi.org/10.1101/2020.10.16.20213843
AA Kibitov
1V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russian Federation
AS Rakitko
1V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russian Federation
2Genotek Ltd., Moscow, Russian Federation
ED Kasyanov
1V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russian Federation
GV Rukavishnikov
1V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russian Federation
KA Kozlova
3Lomonosov Moscow State University, Moscow, Russian Federation
VV Ilinsky
1V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russian Federation
2Genotek Ltd., Moscow, Russian Federation
NG Neznanov
1V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russian Federation
4First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russian Federation
GE Mazo
1V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russian Federation
AO Kibitov
1V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russian Federation
5Serbsky National Medical Research Center on Psychiatry and Addictions, Moscow, Russian Federation
Article usage
Posted October 20, 2020.
Evaluation of applicability of the online version of HADS-D for depression phenotype screening in the general population
AA Kibitov, AS Rakitko, ED Kasyanov, GV Rukavishnikov, KA Kozlova, VV Ilinsky, NG Neznanov, GE Mazo, AO Kibitov
medRxiv 2020.10.16.20213843; doi: https://doi.org/10.1101/2020.10.16.20213843
Evaluation of applicability of the online version of HADS-D for depression phenotype screening in the general population
AA Kibitov, AS Rakitko, ED Kasyanov, GV Rukavishnikov, KA Kozlova, VV Ilinsky, NG Neznanov, GE Mazo, AO Kibitov
medRxiv 2020.10.16.20213843; doi: https://doi.org/10.1101/2020.10.16.20213843
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2300)
- Dermatology (205)
- Emergency Medicine (372)
- Epidemiology (11633)
- Forensic Medicine (10)
- Gastroenterology (685)
- Genetic and Genomic Medicine (3638)
- Geriatric Medicine (342)
- Health Economics (624)
- Health Informatics (2335)
- Health Policy (921)
- Hematology (336)
- HIV/AIDS (761)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3393)
- Nursing (193)
- Nutrition (512)
- Oncology (1783)
- Ophthalmology (527)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6031)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (144)